Dr. Andre Lamy

Dr. Andre Lamy is a cardiac surgeon at the Hamilton Health Sciences. He is a Professor in the Department of Surgery at McMaster University and is a scientist at the Population Health Research Institute in Hamilton. 
 
Dr. Lamy was the PI of the CORONARY trial, a large multi centered randomized trial of off-pump CABG surgery versus on-pump CABG surgery. Dr. Lamy is also leading the COMPASS-CABG, a RCT evaluating the benefits of rivaroxaban for graft patency after CABG surgery but also investigating the poor patency of the skeletonization technique of the internal mammary artery. Dr. Lamy is co-leading the VISION-Cardiac surgery study, a prospective analysis of 15,000 patients to determine the cut-off value and prognostic factor of high sensitivity troponin essays after cardiac surgery. Dr. Lamy also has expertise in health economics.